Immutrix Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
0
Ending by 2030
Jan 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 19, 2027The maintenance fee for Therapeutic compositions for viral-associated disease states and methods of making and using same (US 11,759,561) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
- 1 fee due Jun 12, 2027The maintenance fee for Therapeutic detoxification compositions and methods of making and using same (US 11,839,628) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
- 1 fee due Aug 13, 2027The maintenance fee for Therapeutic Compositions for Viral-Associated Disease States and Methods of Making and Using Same (US 11,896,753) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
- 2 fees due Sep 5 to 8, 2027 · next Sep 5
- 1 fee due Oct 14, 2027The maintenance fee for Therapeutic Compositions for Viral-Associated Disease States and Methods of Making and Using Same (US 10,617,813) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,278,170 | Carbon and its use in blood cleansing applications In force · From the USPTO record | In force | From the USPTO record | |
| US 9,669,151 | Therapeutic compositions for viral-associated disease states and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 12,409,261 | Therapeutic compositions for viral-associated disease states and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,137,151 | Therapeutic detoxification compositions and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,960,022 | Therapeutic detoxification compositions and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 12,544,401 | Therapeutic Detoxification Compositions and Methods of Making and Using Same In force · Low confidence | In force | Low confidence | |
| US 11,759,561 | Therapeutic compositions for viral-associated disease states and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,839,628 | Therapeutic detoxification compositions and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,773,011 | Therapeutic compositions for viral-associated disease states and methods of making and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,918,728 | Therapeutic compositions for viral-associated disease states and methods of making and using same In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 no status recorded